RPA1 and colonic neoplasm: To assess endogenous cellular RPA acetylation, in the presence and absence of p300, we used the colon cancer p300 wild-type (wt) cell line HCT116 and a p300 deficient cell line (HCT116p300-) derived by targeting the exon two of the P300 gene.